Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study (Q28368332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J Rosing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Middeldorp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Curvers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Christella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L G Thomassen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G A Nicolaes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B N Bouma

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H R Büller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M H Prins

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Tans

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2036-2040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

Oral contraceptives and cardiovascular disease (first of two parts).

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

The 1995 pill scare revisited: anatomy of a non-epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Newer oral contraceptives and the risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

End of the line for "third-generation-pill" controversy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Blood coagulation and oral contraceptives. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Bias versus causality: interpreting recent evidence of oral contraceptive studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Molecular biology and pathophysiology of APC resistance: current insights and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Oral contraceptives and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2906092-4

7 January 2021

10.1016/S0140-6736(99)06092-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10636369%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference